Truvada - Gilead Sciences, Inc.
... once daily taken orally with or without food. (2.1) Recommended dose in pediatric patients weighing greater than or equal to 17 kg and able to swallow a whole tablet: one TRUVADA ...
... once daily taken orally with or without food. (2.1) Recommended dose in pediatric patients weighing greater than or equal to 17 kg and able to swallow a whole tablet: one TRUVADA ...
REPORT OF THE GRAND JURY R. SETH WILLIAMS District Attorney
... inside. The clinic reeked of animal urine, courtesy of the cats that were allowed to roam (and defecate) freely. Furniture and blankets were stained with blood. Instruments were not properly sterilized. Disposable medical supplies were not disposed of; they were reused, over and over again. Medical ...
... inside. The clinic reeked of animal urine, courtesy of the cats that were allowed to roam (and defecate) freely. Furniture and blankets were stained with blood. Instruments were not properly sterilized. Disposable medical supplies were not disposed of; they were reused, over and over again. Medical ...
product monograph
... There may be increased difficulty in treating an allergic type reaction in patients on beta-blockers. In these patients, the reaction may be more severe due to pharmacological effects of beta-blockers and problems with fluid changes. Epinephrine should be administered with caution since it may not ...
... There may be increased difficulty in treating an allergic type reaction in patients on beta-blockers. In these patients, the reaction may be more severe due to pharmacological effects of beta-blockers and problems with fluid changes. Epinephrine should be administered with caution since it may not ...
CIPRO XL PRODUCT MONOGRAPH
... fluoroquinolone-associated tendinitis and tendon rupture is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart, or lung transplants. Factors, in addition to age and corticosteroid use, that may independently i ...
... fluoroquinolone-associated tendinitis and tendon rupture is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart, or lung transplants. Factors, in addition to age and corticosteroid use, that may independently i ...
PrCIPRO® XL
... fluoroquinolone-associated tendinitis and tendon rupture is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart, or lung transplants. Factors, in addition to age and corticosteroid use, that may independently i ...
... fluoroquinolone-associated tendinitis and tendon rupture is further increased in older patients usually over 60 years of age, in patients taking corticosteroid drugs, and in patients with kidney, heart, or lung transplants. Factors, in addition to age and corticosteroid use, that may independently i ...
TAXUS® Liberté™
... TAXUS Stent compared to bare-metal stents have not been associated with an increased risk of cardiac death, myocardial infarction, or all-cause mortality. Additional data from longer-term follow-up in the randomized clinical trials on the TAXUS Stent and analyses of DES-related stent thrombosis are ...
... TAXUS Stent compared to bare-metal stents have not been associated with an increased risk of cardiac death, myocardial infarction, or all-cause mortality. Additional data from longer-term follow-up in the randomized clinical trials on the TAXUS Stent and analyses of DES-related stent thrombosis are ...
Low-Dose Methotrexate: A Mainstay in the Treatment of Rheumatoid
... from studies performed in cell culture is always difficult because of the differences among cell lines and the questionable relevance of a particular measure to the pathogenesis of the disease under study. With methotrexate, these studies are even more difficult to interpret because the effects of m ...
... from studies performed in cell culture is always difficult because of the differences among cell lines and the questionable relevance of a particular measure to the pathogenesis of the disease under study. With methotrexate, these studies are even more difficult to interpret because the effects of m ...
Gemcitabine 1g Powder for Solution for Infusion
... gemcitabine and cisplatin should be considered one of the more effective combinations in advanced NSCLC. In the elderly, gemcitabine is an example of a single agent of choice in NSCLC. The clinical overview adds that many chemotherapy drugs have been evaluated in pancreatic cancer and that the resul ...
... gemcitabine and cisplatin should be considered one of the more effective combinations in advanced NSCLC. In the elderly, gemcitabine is an example of a single agent of choice in NSCLC. The clinical overview adds that many chemotherapy drugs have been evaluated in pancreatic cancer and that the resul ...
FREE BONUS offer! - Colgate Professional
... Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in ...
... Potential adverse reproductive effects of fluoride exposure in humans has not been adequately evaluated. Adverse effects on reproduction were reported for rats, mice, fox, and cattle exposed to 100 ppm or greater concentrations of fluoride in their diet or drinking water. Other studies conducted in ...
Extended-Release Tablets, USP (SR)
... No suicides occurred in any of the pediatric trials. There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide. It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months. However, there is ...
... No suicides occurred in any of the pediatric trials. There were suicides in the adult trials, but the number was not sufficient to reach any conclusion about drug effect on suicide. It is unknown whether the suicidality risk extends to longer-term use, i.e., beyond several months. However, there is ...
Digoxin Injection, CSD
... heart failure. Digoxin Injection increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Injection should be used wit ...
... heart failure. Digoxin Injection increases left ventricular ejection fraction and improves heart failure symptoms as evidenced by exercise capacity and heart failure-related hospitalizations and emergency care, while having no effect on mortality. Where possible, Digoxin Injection should be used wit ...
PRODUCT MONOGRAPH N SANDOZ FENTANYL PATCH
... Sandoz Fentanyl Patch should not be used in the management of acute or postoperative pain since there is no opportunity for dose titration during short-term use and serious or life-threatening hypoventilation could result. Similarly, Sandoz Fentanyl Patch should not be administered to patients who d ...
... Sandoz Fentanyl Patch should not be used in the management of acute or postoperative pain since there is no opportunity for dose titration during short-term use and serious or life-threatening hypoventilation could result. Similarly, Sandoz Fentanyl Patch should not be administered to patients who d ...
The Global Asthma Report 2014
... required actions. Included are findings from new GAN surveys on asthma guidelines, national asthma strategies and access to quality-assured, affordable asthma medicines. Designed for government ministers, policy-makers, health authorities, health professionals, patient support organisations and peop ...
... required actions. Included are findings from new GAN surveys on asthma guidelines, national asthma strategies and access to quality-assured, affordable asthma medicines. Designed for government ministers, policy-makers, health authorities, health professionals, patient support organisations and peop ...
levocarb CR
... When appropriate, levodopa therapy may also be initiated with LEVOCARB CR 200 mg/50 mg. The initial recommended dose in patients with mild to moderate disease is 1 tablet of LEVOCARB CR 200 mg/50 mg two times daily. Initial dosages should not exceed 600 mg per day of levodopa or be given at interva ...
... When appropriate, levodopa therapy may also be initiated with LEVOCARB CR 200 mg/50 mg. The initial recommended dose in patients with mild to moderate disease is 1 tablet of LEVOCARB CR 200 mg/50 mg two times daily. Initial dosages should not exceed 600 mg per day of levodopa or be given at interva ...
product monograph - Takeda Canada Inc.
... was increased in patients who received high-dose, defined as multiple daily doses, and longterm PPI therapy (a year or longer). Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated. Patients at risk for osteoporosisrelated fractures shou ...
... was increased in patients who received high-dose, defined as multiple daily doses, and longterm PPI therapy (a year or longer). Patients should use the lowest dose and shortest duration of PPI therapy appropriate to the condition being treated. Patients at risk for osteoporosisrelated fractures shou ...
MICROMEDEX® Healthcare Series Document
... increase dosage 5 to 10 mg/kg/week to achieve optimal clinical response (MAX 60 mg/kg/day or less wit serum range of 50 to 100 mcg/mL) (Prod Info DEPAKENE(R) oral capsules, oral syrup, 2006; Prod Info S delayed release oral capsules, 2008) 2) conversion to monotherapy, 10 to 15 mg/kg/day ORALLY (giv ...
... increase dosage 5 to 10 mg/kg/week to achieve optimal clinical response (MAX 60 mg/kg/day or less wit serum range of 50 to 100 mcg/mL) (Prod Info DEPAKENE(R) oral capsules, oral syrup, 2006; Prod Info S delayed release oral capsules, 2008) 2) conversion to monotherapy, 10 to 15 mg/kg/day ORALLY (giv ...
101 SIGN British Guideline on the Management of Asthma
... collaboration with Asthma UK, the Royal College of Physicians of London, the Royal College of Paediatrics and Child Health, the General Practice Airways Group, and the British Association of Accident and Emergency Medicine (now the College of Emergency Medicine). The outcome of these efforts was the ...
... collaboration with Asthma UK, the Royal College of Physicians of London, the Royal College of Paediatrics and Child Health, the General Practice Airways Group, and the British Association of Accident and Emergency Medicine (now the College of Emergency Medicine). The outcome of these efforts was the ...
product monograph
... Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine; an initial dose of one tablet daily is recommended. Use in Elderly: In patients 60 years of age or older, sympathomimetics are also more likely to cause adverse re ...
... Patients with severe liver impairment should be administered a lower initial dose because they may have reduced clearance of loratadine; an initial dose of one tablet daily is recommended. Use in Elderly: In patients 60 years of age or older, sympathomimetics are also more likely to cause adverse re ...
Developing Cures, Creating Jobs
... of the drug development and approval process—they account for 45 to 75 percent of the $1.2 billion average cost of developing a new drug and are conducted to determine the safety and effectiveness of that treatment in patients. Some trials are also conducted to compare existing treatments and some a ...
... of the drug development and approval process—they account for 45 to 75 percent of the $1.2 billion average cost of developing a new drug and are conducted to determine the safety and effectiveness of that treatment in patients. Some trials are also conducted to compare existing treatments and some a ...
British Guideline on the Management of Asthma
... collaboration with Asthma UK, the Royal College of Physicians of London, the Royal College of Paediatrics and Child Health, the General Practice Airways Group, and the British Association of Accident and Emergency Medicine (now the College of Emergency Medicine). The outcome of these efforts was the ...
... collaboration with Asthma UK, the Royal College of Physicians of London, the Royal College of Paediatrics and Child Health, the General Practice Airways Group, and the British Association of Accident and Emergency Medicine (now the College of Emergency Medicine). The outcome of these efforts was the ...
Document PDF - PUMA
... Research, Vienna, Austria Purpose: Splenectomy is associated with complex venous thromboembolism such as recurrent deep venous thrombosis, portal vein thrombosis, and chronic thromboembolic pulmonary hypertension (CTEPH). The spleen serves not only as a red blood cell filter but also constitutes an ...
... Research, Vienna, Austria Purpose: Splenectomy is associated with complex venous thromboembolism such as recurrent deep venous thrombosis, portal vein thrombosis, and chronic thromboembolic pulmonary hypertension (CTEPH). The spleen serves not only as a red blood cell filter but also constitutes an ...
Outcomes and Impacts of Blow-out Fractures of The Orbit
... without orbital rim involvement. The management of this injury and its timing continue to be a matter of some debate. One of the main reasons for this debate is the lack of unifying objective, quantitative, clinical measures of diplopia severity that encompass both the clinical and patient perspecti ...
... without orbital rim involvement. The management of this injury and its timing continue to be a matter of some debate. One of the main reasons for this debate is the lack of unifying objective, quantitative, clinical measures of diplopia severity that encompass both the clinical and patient perspecti ...
terminology guidelines glaucoma
... of glaucoma in patients with ocular hypertension (OH)19. 1,636 patients were recruited. Randomization was between treatment with IOP lowering medications and no treatment. The treatment goal was to lower the IOP to < 24 mmHg and at least 20% from baseline. The primary outcome was the development of ...
... of glaucoma in patients with ocular hypertension (OH)19. 1,636 patients were recruited. Randomization was between treatment with IOP lowering medications and no treatment. The treatment goal was to lower the IOP to < 24 mmHg and at least 20% from baseline. The primary outcome was the development of ...